» Articles » PMID: 23306781

Optimization of Human Umbilical Cord Mesenchymal Stem Cell Isolation and Culture Methods

Overview
Journal Cytotechnology
Specialties Biotechnology
Genetics
Date 2013 Jan 12
PMID 23306781
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Human umbilical cord mesenchymal stem cells (hUCMSCs) are considered to be an ideal replacement for bone marrow MSCs. However, up to date, there is no convenient and efficient method for hUCMSC isolation and culture. The present study was carried out to explore the modified enzyme digestion for hUCMSC in vitro. Conventional enzyme digestion, modified enzyme digestion, and tissue explant were used on hUCMSCs to compare their efficiencies of isolation and culture, to observe primary cell growth and cell subculture. The results show that the cells cultured using the tissue explant method had a longer culture cycle (P < 0.01) and lower yield of primary cells per centimetre of umbilical cord (P < 0.01) compared with the two enzyme digestion methods. Subculture adherence and cell doubling took significantly less time with the tissue explant method (P < 0.05) than with the conventional enzyme digestion method; however, there was no significant difference between the tissue explant method and the modified enzyme digestion method (P > 0.05). Comparing two enzyme digestion methods, the modified method yielded more cells than did the conventional method (P < 0.01), and primary cell adherence took significantly less time with the modified method than with the conventional method (P < 0.05). Cell cycle analysis of the third-generation hUCMSCs cultured by modified enzyme digestion method indicated that most cells were quiescent. Immunofluorescence staining showed that these cells expressed MSC markers CD44 and CD90. And Von Kossa and oil red O staining detection showed that they could be differentiated into osteoblasts and adipocytes with induction medium in vitro. This study suggests that hUCMSC isolation and culture using 0.2 % collagenase II at 37 °C for digestion of 16-20 h is an effective and simple modified enzyme digestion method.

Citing Articles

Therapeutic potential of EVs loaded with CB2 receptor agonist in spinal cord injury via the Nrf2/HO-1 pathway.

Shaikh I, Bhandari R, Singh S, Zhu X, Shahzad K, Shao C Redox Rep. 2024; 29(1):2420572.

PMID: 39466990 PMC: 11520104. DOI: 10.1080/13510002.2024.2420572.


Chondrogenic Potential of Umbilical Cord-Derived Mesenchymal Stromal Cells: Insights and Innovations.

Jeyaraman N, Jeyaraman M, Muthu S, Balaji S, Ramasubramanian S, Patro B Indian J Orthop. 2024; 58(10):1349-1361.

PMID: 39324097 PMC: 11420429. DOI: 10.1007/s43465-024-01239-8.


A GMP-compliant manufacturing method for Wharton's jelly-derived mesenchymal stromal cells.

Chu W, Zhang F, Zeng X, He F, Shang G, Guo T Stem Cell Res Ther. 2024; 15(1):131.

PMID: 38702793 PMC: 11069138. DOI: 10.1186/s13287-024-03725-0.


Integrin beta 3-overexpressing mesenchymal stromal cells display enhanced homing and can reduce atherosclerotic plaque.

Hu H, Xiao X, Li T, Liu D, Geng X, Han M World J Stem Cells. 2023; 15(9):931-946.

PMID: 37900938 PMC: 10600744. DOI: 10.4252/wjsc.v15.i9.931.


Quality Control Optimization for Minimizing Security Risks Associated with Mesenchymal Stromal Cell-Based Product Development.

Rebelatto C, Boldrini-Leite L, Daga D, Marsaro D, Vaz I, Jamur V Int J Mol Sci. 2023; 24(16).

PMID: 37629136 PMC: 10455270. DOI: 10.3390/ijms241612955.


References
1.
Qiao C, Xu W, Zhu W, Hu J, Qian H, Yin Q . Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int. 2007; 32(1):8-15. DOI: 10.1016/j.cellbi.2007.08.002. View

2.
Can A, Karahuseyinoglu S . Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells. 2007; 25(11):2886-95. DOI: 10.1634/stemcells.2007-0417. View

3.
Schneider R, Pullen A, Kramann R, Bornemann J, Knuchel R, Neuss S . Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents. Differentiation. 2010; 79(3):182-93. DOI: 10.1016/j.diff.2010.01.005. View

4.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7. DOI: 10.1080/14653240600855905. View

5.
Pittenger M, Mackay A, Beck S, Jaiswal R, Douglas R, Mosca J . Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284(5411):143-7. DOI: 10.1126/science.284.5411.143. View